This article first appeared on GuruFocus .
-
DET Revenue:$163.5 million in Q4 FY26, a 2.4% sequential decline in constant currency and a 1.5% year-on-year decline in constant currency.
-
DET Revenue in INR:INR 1,500 crore, reflecting 0.8% quarter-on-quarter growth and 7.4% year-on-year growth.
-
DET Gross Margin:38.9% in Q4, a 114 basis point sequential improvement.
-
DET EBIT Margin:12.4% in Q4.
-
DET PAT:INR 138 crore in Q4, a 7.6% sequential and 9.1% year-on-year decline.
-
DET Free Cash Flow:INR 225 crore in Q4, representing a 163% conversion of PAT.
-
Group Revenue:$209.9 million in Q4, a 0.9% sequential growth and a 7.2% year-on-year decline.
-
Group Revenue in INR:INR 1,927 crore in Q4.
-
Group EBIT Margin:9.5% for the full year, a 254 basis points year-on-year contraction.
-
Group PAT:INR 534 crore for the full year, a 14.3% year-on-year decline.
-
Buyback Proposal:Up to 6.4 million equity shares at INR 11.25 per share, not exceeding INR 720 crore.
-
Warning! GuruFocus has detected 3 Warning Sign with BOM:532175.
-
Is BOM:532175 fairly valued? Test your thesis with our free DCF calculator.
Release Date: April 23, 2026
For the complete transcript of the earnings call, please refer to the full earnings call transcript .
Positive Points
-
Cyient Ltd ( BOM:532175 ) reported a 5% sequential improvement in semiconductor revenue, marking the fourth consecutive quarter of growth in this segment.
-
The company successfully closed a 74% majority stake in Kinetic Technologies, enhancing its proprietary strength in power products.
-
Cyient Ltd ( BOM:532175 ) announced a buyback of up to 6.4 million equity shares, reflecting confidence in the company's intrinsic value.
-
The company secured a multi-year framework agreement with a leading global rail OEM, strengthening its position as a strategic supplier.
-
Cyient Ltd ( BOM:532175 ) reported a healthy order book and a mature pipeline for FY27, indicating strong future growth potential.
Negative Points
-
The DET segment experienced a 2.4% sequential decline in constant currency revenue, indicating challenges in maintaining growth momentum.
-
The company reported a negative EBIT for the semiconductor segment due to ongoing investments in team building and intellectual property.
-
Geopolitical uncertainties and AI developments led to a pause in Project Astro, resulting in a significant charge against the P&L for due diligence expenses.
-
Revenue growth was modest despite a strong pipeline, with delays in client budget deployments impacting quarterly performance.
-
The strategic units segment saw a 12.4% quarter-over-quarter decline, with challenges in energy and connectivity sectors affecting growth.
Q & A Highlights
Q: Can you quantify the exposure to West Asia in terms of revenue for the DET business and potential headwinds? A: Our direct exposure to West Asia is not significant. We work with Tier 1 EPC companies servicing the energy market, which is more project-based. It's difficult to assess exact numbers, but it's not a significant portion of our business. However, we had built up a pipeline in the Middle East, which was on the verge of closure.
Q: Can you provide details about Project Astro and the type of asset involved? A: Project Astro is a transformative acquisition, but due to NDAs, we can't disclose specifics. It's a significant transaction, and we are pausing to reassess due to rapid AI evolution and geopolitical uncertainties.
Q: Regarding the potential liquidity raise for the semiconductor business, what kind of dilution are you considering? A: The initial raise will be small, covering working capital needs, with a dilution of about 10-12% of equity. Depending on business evolution and capital needs, we may reassess, but the first raise will not exceed 10-12%.
Q: Despite a strong pipeline, revenue growth has been modest. Can you explain the pipeline to revenue conversion timeline and delays? A: The issue was not pipeline conversion but delays in program starts by three key customers due to budget allocations. Typically, 75% of our order book converts to revenue within nine months. The delays were specific to Q4 and will not impact Q1.
Q: How do you reconcile returning cash via buyback while exploring a fundraise? A: The buyback is for Cyient, while the fundraise is for Cyient Semiconductor. The buyback reflects our capital requirements and share price, while the fundraise aims to establish Cyient Semiconductor's independent value and capital structure.
For the complete transcript of the earnings call, please refer to the full earnings call transcript .
